Were you an investor who purchased ADMA securities within the period from August 9, 2024, to March 25, 2026? ADMA Biologics, Inc. (NASDAQ: ADMA) is facing a securities fraud class action lawsuit during this Class Period. Investors who purchased securities during this time frame are considered affected. The deadline for seeking Lead Plaintiff Status in the lawsuit is upcoming.